CX3CL1 as a Regulator of Ovarian Cancer Cell Growth
Author Information
Author(s): Gaudin Françoise, Nasreddine Salam, Donnadieu Anne-Claire, Emilie Dominique, Combadière Christophe, Prévot Sophie, Machelon Véronique, Balabanian Karl
Primary Institution: UMR_S996, INSERM/Université Paris-Sud 11, Clamart, France
Hypothesis
The chemokine CX3CL1 plays a significant role in the proliferation of malignant ovarian epithelial cells.
Conclusion
CX3CL1 is constitutively expressed in ovarian epithelial cells and regulates cell proliferation, which may have clinical implications for ovarian cancer treatment.
Supporting Evidence
- CX3CL1 was detected in both healthy and malignant ovarian tissues.
- Immunoreactivity for CX3CL1 was positively correlated with the proliferation index Ki-67.
- GILZ overexpression in cancer cells increased CX3CL1 levels and tumor growth.
- CX3CL1 promoted cell proliferation through its receptor CX3CR1.
- Hierarchical clustering analysis distinguished two major clusters of tumor specimens based on proliferation levels.
Takeaway
This study found that a protein called CX3CL1 helps ovarian cancer cells grow, which could be important for finding better treatments.
Methodology
The study used immunohistochemistry, RT-PCR, and xenograft models to analyze CX3CL1 expression and its effects on cell proliferation.
Potential Biases
Potential biases may arise from the selection of tumor specimens and the interpretation of immunohistochemical data.
Limitations
The study's findings are based on a relatively small sample size and may not be generalizable to all ovarian cancer types.
Participant Demographics
The study involved 54 women who underwent surgical treatment for epithelial ovarian cancer.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website